← Back to Search


Contoura with Phorcides and WaveLight Wavefront Optimized for Near-sightedness and Astigmatism

Research Sponsored by Daniel Terveen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
Pre-operative total corneal Pachymetry 490um or above
Must not have
Be younger than 18 years old
Be older than 65 years old
Screening 3 weeks
Treatment Varies
Follow Up3 months post-op
Awards & highlights
No Placebo-Only Group

Study Summary

This trial compares two different types of LASIK surgery to see which one results in better vision and patient satisfaction.

Eligible Conditions
  • Near-sightedness
  • Astigmatism

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You are in good health overall, including your eyes.
The study only includes participants with normal vision (no need for glasses) in both eyes.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-Op UDVA
Secondary outcome measures
Corrected Distance Visual Acuity
Low Contrast Visual Acuity
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Study: PhorcidesExperimental Treatment1 Intervention
Contoura with Phorcides used for surgical planning of LASIK procedure
Group II: Control: Wavefront OptimizedActive Control1 Intervention
WaveLight Wavefront Optimized used for surgical planning of LASIK procedure

Find a Location

Who is running the clinical trial?

Daniel TerveenLead Sponsor
Alcon ResearchIndustry Sponsor
694 Previous Clinical Trials
123,732 Total Patients Enrolled

Media Library

Contoura with Phorcides (LASIK) Clinical Trial Eligibility Overview. Trial Name: NCT05486546 — N/A
Near-sightedness Research Study Groups: Study: Phorcides, Control: Wavefront Optimized
Near-sightedness Clinical Trial 2023: Contoura with Phorcides Highlights & Side Effects. Trial Name: NCT05486546 — N/A
Contoura with Phorcides (LASIK) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05486546 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Might I qualify for inclusion in this research project?

"Aspiring participants of this clinical study must have myopia and be aged between 21 and 38. The trial is anticipating to enrol 120 patients."

Answered by AI

Are new participants being recruited for this experiment at the moment?

"According to information hosted on clinicaltrials.gov, this experiment is not seeking participants at the moment. The study was first listed on August 15th 2022 and had its last update a few weeks ago on the 1st of August 2022. Despite that, there are still 129 other studies currently recruiting individuals for their trials."

Answered by AI

Does the protocol for this trial encompass individuals older than seventy years?

"This research is enrolling individuals in the age group of 21 and 38 years old."

Answered by AI

Who else is applying?

What state do they live in?
South Dakota
What site did they apply to?
Vance Thompson Vision
What portion of applicants met pre-screening criteria?
Met criteria
~53 spots leftby Nov 2024